FDA Import Refusal AEK-9586606-5/10002/1 — CIPLA HEALTH LTD
The FDA refused shipment AEK-9586606-5/10002/1 from CIPLA HEALTH LTD (India) on Aug 11, 2026. The refused product falls under Drugs and Biologics — GLYHEXAMIDE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 11, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCC13 GLYHEXAMIDE (ANTI-DIABETIC)
- Charges
- 118,75